New Topical Treatment for Continued Pain After Shingles

Completed · Phase 1

Conditions studied: Postherpetic Neuralgia

In brief

Shingles is an outbreak of rash or blisters on the skin that is caused by the same virus that causes chicken pox. Some people experience continued pain even after the shingles rash and blisters have healed; this pain is known as postherpetic neuralgia. The purpose of this study is to evaluate the effectiveness of a new topical treatment for postherpetic neuralgia in adults.

Key facts

Study ID

NCT00566904

Run by

Biomedical Development Corporation

People needed

30

Starts

2006-09-01

Expected to finish

2008-09-01

Last updated by the study team

2011-08-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• In good general health
• Postherpetic neuralgia, defined as pain persisting more than 4 months after onset of herpes zoster outbreak
• Willing to use effective forms of contraception for the duration of the study

You may not qualify if…

• Known lidocaine sensitivity or allergy
• Inability to discontinue use of any nonstudy lidocaine-containing products for the duration of the study
• Known hypersensitivity to aspirin
• Open herpes zoster blisters
• Known sensitivity or allergy to an amide-type local anesthetic agent
• Existing conditions that make participation unsafe
• Pregnant
• Immunocompromised (e.g., HIV infected)
• Herpes zoster in any dermatome (area of skin innervated by a specific sensory nerve) affecting the face or scalp
• Affected skin area is greater than 420 square cm
• Affected area includes skin breakdown or nonintact skin
• Affected area consists of more than one contiguous area

Where it is running

• Dermatology Clincial Reseach Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.